"iDoctor – Medical Blog"

CLEVELAND (MedPage Today) — The makers of ezetimibe (Zetia) and ezetimibe/simvastatin (Vytorin) will pay $5.4 million to settle charges that the company violated consumer protection laws by delaying public release of negative findings from a clinical trial.

This entry was posted on Friday, July 17th, 2009 at 3:14 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.